CinRx Pharma develops therapies for unmet needs, leveraging partnerships and expertise to advance new molecular entities.
CinRx Pharma has raised $73.0M in total funding. The most recent round was Series B. The last funding was announced in May 2024.
CinRx Pharma is headquartered in Cincinnati, United States.
CinRx Pharma develops therapies for unmet needs, leveraging partnerships and expertise to advance new molecular entities.
CinRx Pharma is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CinRx Pharma — Funding & Investors." VCBacked, May 30, 2024, https://www.vcbacked.co/company/cinrx-pharma. Accessed August 1, 2026.
VCBacked. (2024). CinRx Pharma — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/cinrx-pharma
{{cite web |title=CinRx Pharma — Funding & Investors |url=https://www.vcbacked.co/company/cinrx-pharma |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated